Low-dose anti-thymocyte globulin combined with low-dose post-transplant cyclophosphamide: a novel approach to prevent graft-versus-host disease in haploidentical stem cell transplantation
The combination of low-dose ATG and PTCy appears to significantly reduce moderate cGVHD and NRM in haplo-HSCT compared to PTCy alone. To the best of our knowledge, this is the first study directly comparing these two regimens.
Authors
- Ali Ünal (ORCID: https://orcid.org/0000-0001-7011-3412)
- Neslihan Mandacı Şanlı (ORCID: https://orcid.org/0000-0002-6298-9884)
Institutions
- Erciyes University (TR)
Publication Details
- Journal
- Therapeutic Advances in Hematology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1177/20406207251353011
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00